Panuveitis Presumed Secondary to Ibrutinib Therapy

被引:3
作者
Arepalli, Sruthi [1 ]
Srivastava, Sunil K. [1 ]
Baynes, Kimberly [1 ]
Venkat, Arthi G. [1 ]
机构
[1] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA
关键词
D O I
10.3928/23258160-20210302-08
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Although a small number of cases of secondary uveitis have been documented in the setting of ibrutinib therapy, panuveitis has not previously been described with this medication. The authors describe a presumed case of panuveitis in a patient on ibrutinib for chronic lymphocytic leukemia. The purpose of this report is to document a case of asymmetric, bilateral panuveitis in the setting of ibrutinib use. Panuveitis may develop in the setting of ibrutinib use, and local steroid therapy can be successfully used for treatment without cessation of systemic cancer therapy.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 12 条
[1]   UVEITIS AFTER ANTINEUTROPHIL CYTOPLASMIC ANTIBODY CONTAMINATION OF IMMUNOGLOBULIN REPLACEMENT THERAPY [J].
AYLIFFE, W ;
HAENEY, M ;
ROBERTS, SC ;
LAVIN, M .
LANCET, 1992, 339 (8792) :558-559
[2]   Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse [J].
Bernard, Sophie ;
Goldwirt, Lauriane ;
Amorim, Sandy ;
Brice, Pauline ;
Briere, Josette ;
de Kerviler, Eric ;
Mourah, Samia ;
Sauvageon, Helene ;
Thieblemont, Catherine .
BLOOD, 2015, 126 (14) :1695-1698
[3]   Uveitic macular oedema after treatment with vemurafenib [J].
Fonollosa, Alex ;
Mesquida, Marina ;
Adan, Alfredo .
ACTA OPHTHALMOLOGICA, 2015, 93 (08) :E686-E687
[4]   Chronic lymphocytic leukemia masquerading as uveitis [J].
Gupta, Gaurav ;
Larson, Richard A. ;
Jampol, Lee M. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (09) :1311-1312
[5]   PD0325901, a Mitogen-Activated Protein Kinase Kinase Inhibitor, Produces Ocular Toxicity in a Rabbit Animal Model of Retinal Vein Occlusion [J].
Huang, Wenhu ;
Yang, Amy H. ;
Matsumoto, Diane ;
Collette, Walter ;
Marroquin, Lisa ;
Ko, Mira ;
Aguirre, Shirley ;
Younis, Husam S. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (06) :519-530
[6]  
Kocak Enis D, 2017, Am J Ophthalmol Case Rep, V6, P74, DOI 10.1016/j.ajoc.2017.03.005
[7]   Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: A case report and review of the literature Tina Dietrich [J].
Kolomeyer A.M. ;
Hwang C.K. ;
Kim B.J. .
Journal of Medical Case Reports, 12 (1)
[8]   Knowing the Flip Side of the Coin: Ibrutinib Associated Cystoid Macular Edema [J].
Mirgh, Sumeet P. ;
Ahmed, Rayaz ;
Agrawal, Narendra ;
Bothra, Sneha ;
Mohan, Bhaarat ;
Garg, Ambar ;
Thekkudan, Shinto Francis ;
Khushoo, Vishvdeep ;
Bhurani, Dinesh .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (01) :208-210
[9]   Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib [J].
Saenz-de-Viteri, Manuel ;
Cudrnak, Tomas .
LEUKEMIA & LYMPHOMA, 2019, 60 (03) :842-844
[10]   Ocular toxicity due to Trametinib and Dabrafenib [J].
Sarny, Stephanie ;
Neumayer, Michael ;
Kofler, Julian ;
El-Shabrawi, Yosuf .
BMC OPHTHALMOLOGY, 2017, 17